EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents

Neha Raut iD, Saeed Vohra iD, Pooja Kaushalye iD, Sainath Mane, Divya Malode iD, Milind Umekar iD, Abdulrahman Mohammed Alhudhaibi iD, Anis Ahmad Chaudhary iD, Rashmi Trivedi

International Journal of Molecular Sciences · 08.06.2026 · 27 (12) · 5179

DOI: 10.3390/ijms27125179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.06.2026. Verfasst von Neha Raut und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Immunity, Innate, Antimicrobial Peptides. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imam Mohammad ibn Saud Islamic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential for the use of antimicrobial peptides (AMPs) as anticancer agents has garnered much interest because of their selective cytotoxicity to tumor cells and ability to evade multidrug resistance mechanisms. AMPs are shorter cationic amphiphilic molecules, part of our innate immune system, with direct membrane-disruptive activity and immunomodulatory effects. Anticancer peptides (ACPs) can be derived from natural biophysical sources or synthetically engineered, taking advantage of the unique biophysical properties of cancer cell membranes to exert their anti-tumor activities rapidly and often without significant effects on normal tissues. Advances in peptide engineering, such as D-amino acid substitution, cyclization, and PEGylation, combined with nanocarrier systems, have provided opportunities to improve peptide stability, bioavailability, and delivery to targeted sites. Studies in preclinical and clinical models show promise, indicating that AMPs and ACPs can induce immunogenic cell death, modify tumor microenvironments, and be used in combination with more conventional therapies. While the promise of AMPs and ACPs as relatively novel cancer therapeutics is substantial, challenges such as proteolytic degradation, dose-dependent toxicity, costs for production, and regulatory hurdles are notable. This review organizes the current literature on classification, mechanism(s) of action, delivery strategies, preclinical and clinical data, and provides areas for future work to improve and help speed their clinical translation as new cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsImmunity, InnateAntimicrobial PeptidesAntimicrobial Cationic PeptidesHumansAnimals

Stichwörter der Autor:innen

anticancer peptidesantimicrobial peptidescancer therapyimmunogenic cell deathnanocarrier delivery

Substanzen

Antineoplastic AgentsAntimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, India.
  • Department of Anatomy and Physiology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
  • Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Nagpur 441002, India.
  • Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.

ORCID-Profile: Neha Raut, Saeed Vohra, Pooja Kaushalye, Divya Malode, Milind Umekar, Abdulrahman Mohammed Alhudhaibi, Anis Ahmad Chaudhary

Förderung

  • Imam Mohammad ibn Saud Islamic University

Zitieren

APA

Raut, N., Vohra, S., Kaushalye, P., Mane, S., Malode, D., Umekar, M., Alhudhaibi, A. M., Chaudhary, A. A., & Trivedi, R. (2026). From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents. International Journal of Molecular Sciences, 27(12), 5179. https://doi.org/10.3390/ijms27125179

Vancouver

Raut N, Vohra S, Kaushalye P, Mane S, Malode D, Umekar M, et al. From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents. International Journal of Molecular Sciences. 2026;27(12):5179. doi:10.3390/ijms27125179

BibTeX
@article{Raut2026,
  author = {Raut, Neha and Vohra, Saeed and Kaushalye, Pooja and Mane, Sainath and Malode, Divya and Umekar, Milind and Alhudhaibi, Abdulrahman Mohammed and Chaudhary, Anis Ahmad and Trivedi, Rashmi},
  title = {From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5179},
  doi = {10.3390/ijms27125179}
}
Kostenlos starten →